Products

This is a seasonal limited production run. Available to pre-order now through July, 2010. Product will ship mid-end of July.
Download info flier

Eniva Chromium (symbol "Cr") is supplied as trivalent chromium. Most chromium in foods occurs in this trivalent form. Highly refined foods may have diminished chromium levels.*

Minerals for Life^® Chromium is a liquid dietary supplement of the mineral Chromium in a proprietary advanced aqueous nutrient delivery system. The purer the water the more efficiently minerals are activated into their electrically charged ionic state. Eniva uses OHM^® water (multi-step purified water) in a unique proprietary process at Eniva's government-inspected manufacturing facility, yielding a bio-available form of chromium ions (Solutomic^®) in sparkling clear solution for quicker absorption than tablets or capsules which must first dissolve in the digestive system before being absorbed.

Chromium is essential to the metabolism of lipids, glucose, and insulin. Because of its role in these processes, chromium helps the body maintain healthy energy levels and normal mental alertness.*

Chromium Helps to Support:

• Weight Loss*
• Circulatory System Health*
• Maintaining Sugar Balance*
• Healthy LDL and HDL Cholesterol Levels*
• Positive Moods*
• Mental Clarity*
• Healthy Heart Function*
• Feelings of Well-Being*
• Conception*
• Stress Relief*
• Healthy Muscles*
• Normal Growth*

Scientific References

Abraham AS, Brooks BA, and Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin dependent diabetes. Metabolism. 41: 768-771, 1992.

Anderson RA. Chromium in the prevention and control of diabetes. Diabetes & Metabolism. 26(1):22-7, 2000.

Anderson RA. Cheng N. Bryden NA. Polansky MM. Cheng N. Chi J. Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 46(11):1786-91, 1997.

Anderson RA. Chromium, glucose tolerance, and diabetes. Biological Trace Element Research. 32: 19-24, 1992.

Canfield W. Chromium, glucose tolerance and serum cholesterol in adults. In: Shapcott D and Hubert J (eds), Chromium in Nutrition and Metabolism. Amsterdam: Elsevier, 1979.

Clausen J. Chromium induced clinical improvement in symptomatic hypoglycemia. Biological Trace Element Research. 17:229-36, 1988.

Elias AN, Grossman MK and Valenta LJ. Use of the artificial beta cell in the assessment of peripheral insulin sensitivity: Effect of Chromium supplementation in diabetes. General Pharmacology. 15:535-539. 1984.

Elwood JC, Nash DT and Streeten DHP. Effect of high chromium brewer's yeast on human serum lipids. J. Am. Coll. Nutr. 1:263, 1982.

Glinsmann WH and Mertz W. Effect of trivalent chromium on glucose tolerance. Metabolism. 15:510-520, 1966.

Kuritzky L. Samraj GP. Quillen DM. Improving management of type 2 diabetes mellitus:. Chromium. Hospital Practice (Office Edition). 35(2):113-6, 2000.

Lee NA and Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 17: 1449-1452, 1994.

Lefavi RG, et al. Lipid lowering effect of a dietary chromium(III) nicotinic acid complex in male athletes. Nutr. Res. 13:239249, 1993.

Mertz W. Chromium in human nutrition: A review. J. Nutr. 123:626-633, 1993.

Mossop RT. Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics. Central African Journal of Medicine. 29:80-82, 1983.

Offenbach EG and Pi-Sunyer FX. Chromium in human nutrition. Ann. Rev. Nutr. 8:543-563, 1988.

Potter JF. Levin P. Anderson RA. Freiberg JM. Andres R. Elahi D. Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism: Clinical & Experimental. 34(3):199-204, 1985.

Simonoff M. Chromium deficiency and cardiovascular risk. Cardiovascular Research. 18(10):591-6, 1984.

Simonoff M, et al. Low plasma chromium in patients with coronary artery and heart disease. Biol. Trace Elem. Res. 6:431, 1984.

Urberg M. Benyi J. John R. Hypocholesterolemic effects of nicotinic acid and chromium supplementation. Journal of Family Practice. 27(6):603-6, 1988.

Uusitupa MI. Mykkanen L. Siitonen O. Laakso M. Sarlund H. Kolehmainen P. Rasanen T. Kumpulainen J. Pyorala K. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. British Journal of Nutrition. 68(1):209-16, 1992.

Uusipta MI, et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in non-insulin-dependent diabetics. Am. J. Clin. Nutr. 38:404-410, 1983.